Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ravi Paul has a total of 119 co-authors. Here are the top co-authors by number of shared publications:

  • Jeremy C. Kane

    Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA

    5 shared publications
  • Laura K. Murray

    Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    5 shared publications
  • Stephanie Skavenski

    Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    4 shared publications
  • Carla Kmett Danielson

    Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, USA

    3 shared publications
  • Jeremy C. Kane

    Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    3 shared publications
  • John Mayeya

    Zambia Ministry of Health, Lusaka, Zambia

    3 shared publications

Latest Publications

  • Open Access

    Adapting mHealth Interventions to Improve Self-Management of HIV and Reduce Substance Use Among Emerging Adults in Zambia: Protocol for a Randomized Controlled Trial

    by Bo Wang, Karen MacDonell, Joseph Zulu, Ravi Paul, Ben S Gerber, Sylvie Naar, Jayasree Anitha Menon

    Background: Sub-Saharan Africa remains the region most affected by the HIV epidemic, with Zambia experiencing a substantial burden of disease. Young people with HIV are disproportionately impacted. Emerging adulthood (ages 18-24 years) is characterized by increasing independence, risk-taking behaviors, identity exploration, and changing social supports, all of which may impact HIV self-management, including medication adherence and retention in care. Substance use may further undermine HIV outcomes. Innovative interventions targeting HIV self-management and substance use reduction among Zambian young people are urgently needed. Objective: This study aims to develop and pilot a multicomponent mobile health (mHealth) intervention to improve HIV self-management and reduce substance use among young people in Zambia. We will adapt the 4-session in-person Healthy Choices intervention for mobile delivery (mobile Healthy Choices [mHC]) to increase access and delivery. We will also develop motivational text messaging (MTM) to enhance intervention impact. Both components will be delivered using the Computerized Intervention Authoring System. Using the multiphase optimization strategy (MOST) framework, we will assess preliminary efficacy and identify the most effective components. Methods: The study includes 3 phases. Phase 1 will involve conducting focus groups with Zambian young people with HIV to explore barriers and facilitators of HIV self-management and substance use to inform intervention adaptation. Phase 2 will involve adaptation and beta testing of mHC and MTM for functionality and feasibility using a community advisory board. Phase 3 will consist of a pilot trial using the MOST framework to evaluate feasibility, acceptability, and preliminary efficacy of intervention components. A total of 100 young people with HIV will be randomized to one of four experimental conditions: (1) standard antiretroviral therapy (ART) counseling (SAC), (2) mHC+SAC, (3) MTM+SAC, and (4) mHC+MTM+SAC. Primary outcomes will include feasibility, acceptability, ART adherence, viral suppression, and substance use. Feasibility and acceptability will be assessed through paradata of use patterns and the System Usability Scale. Participants will complete assessments at baseline and at 3- and 6-month follow-up visits. Biomarkers of ART adherence and/or sexually transmitted infections will also be collected. Results: Recruitment for this study began in May 2024 for phase 1. Focus group discussions were completed with 48 young people with HIV in July 2024. Phase 3, the pilot feasibility trial, began in June 2025. Upon project completion, we will have developed an innovative mHealth intervention to support HIV self-management and reduce substance use among Zambian young people with HIV. Conclusions: This study addresses a critical problem—suboptimal ART adherence, substance use, and challenges with HIV self-management—among young people with HIV in Zambia. We are developing 2 technology-based, theory-driven intervention components aimed at improving HIV self-management and substance use outcomes. If successful, this study will pave the way for scale-up of mHealth interventions to improve HIV care outcomes among young people with HIV in Zambia and other low-resource settings. Trial Registration: ClinicalTrials.gov NCT06415357; https://clinicaltrials.gov/study/NCT06415357 International Registered Report Identifier (IRRID): DERR1-10.2196/99714

  • Relationship between substance use and socio-behavioral drivers of poor ART adherence among young people with HIV in Zambia

    by Happy Zulu, Bo Wang, Joseph Mumba Zulu, Jayasree Anitha Menon, Ravi Paul, Deogwoon Kim, Anna Bryce, Janelle Renterghem, Karen Macdonell

    Despite improved access to antiretroviral therapy (ART) in Zambia, adherence among young people with HIV (YPHIV) remains suboptimal, compromising treatment effectiveness. YPHIV face unique developmental and socio-behavioral challenges including HIV-related stigma, depression and substance use, which further undermine consistent ART adherence. Alcohol and drug use impair cognitive and emotional functioning, increasing the likelihood of disrupted medication routines. This study applied the Hierarchical Model of Medication Adherence (HMMA) to examine how individual, social and structural factors influence ART adherence among YPHIV in Zambia. A qualitative descriptive design was employed using six focus group discussions (FGDs) with 48 purposively selected participants aged 18-24 years, all reporting <80% adherence and recent substance use. Data were audio-recorded, transcribed verbatim and thematically analyzed. HIV-related stigma, mental health distress and negative healthcare experiences were key drivers of substance use. Substance use impaired adherence by causing forgetfulness and other factors. Depression and emotional exhaustion also emerged as major contributors to substance use and poor adherence. The study offers novel, context-specific insights into the multilevel drivers of poor adherence among Zambian youth aged 18-24. Findings highlight the need for youth-centred interventions that address stigma, mental health and substance use to improve ART adherence and health outcomes.


  • Open Access

    Zimbardo’s Time Perspective and Binge Drinking Patterns in Alcohol Consumption among Black African International University Students in China

    by Alice Nguni, Houchao Lyu, Ravi Paul, Xiaobao Li

    Addictive alcohol use among university students in China is a growing public health concern. This study examines Binge drinking and time perspective among Black African students from Southwest University in China. While the Time Perspective focuses on the past, present, or future that may predict alcohol abuse, its relationship with Binge drinking among Black Africans in China remains unexplored. Among 370 participants, data was gathered using the Time Perspective Inventory and Alcohol Use Disorders Identification Test. Regression analysis indicated a positive association between the present (fatalistic, hedonistic), future, and past-positive TP and binge drinking, while the Future time frame showed an indirect correlation. Age and Sex also correlated with Past Positive and Future time frames. These findings might inform interventions to mitigate heavy drinking on campuses, given students' concerns about future uncertainties.


  • Open Access

    Trends in maternal mental health during the COVID-19 pandemic–evidence from Zambia

    by Irene Falgas-Bague, Thandiwe Thembo, Jeanette L Kaiser, Davidson H Hamer, Nancy A Scott, Thandiwe Ngoma, Ravi Paul, Allison Juntunen, Peter C Rockers, Günther Fink

    The COVID-19 pandemic has increased social and emotional stressors globally, increasing mental health concerns and the risk of psychiatric illness worldwide. To date, relatively little is known about the impact of the pandemic on vulnerable groups such as women and children in low-resourced settings who generally have limited access to mental health care. We explore two rounds of data collected as part of an ongoing trial of early childhood development to assess mental health distress among mothers of children under 5-years-old living in two rural areas of Zambia during the COVID-19 pandemic. We examined the prevalence of mental health distress among a cohort of 1105 mothers using the World Health Organization’s Self-Reporting Questionnaire (SRQ-20) before the onset of the COVID-19 pandemic in August 2019 and after the first two infection waves in October-November 2021. Our primary outcome was mental health distress, defined as SRQ-20 score above 7. We analyzed social, economic and family level characteristics as factors modifying to the COVID-19 induced changes in the mental health status. At baseline, 22.5% of women were in mental health distress. The odds of mental health distress among women increased marginally over the first two waves of the pandemic (aOR1.22, CI 0.99–1.49). Women under age 30, with lower educational background, with less than three children, and those living in Eastern Province (compared to Southern Province) of Zambia, were found to be at highest risk of mental health deterioration during the pandemic. Our findings suggest that the prevalence of mental health distress is high in this population and has further worsened during COVID-19 pandemic. Public health interventions targeting mothers’ mental health in low resource settings may want to particularly focus on young mothers with limited educational attainment.


  • Open Access

    Interpersonal therapy versus antidepressant medication for treatment of postpartum depression and anxiety among women with HIV in Zambia: a randomized feasibility trial

    by M. Bridget Spelke, Ravi Paul, Bryan S. Blette, Samantha Meltzer‐Brody, Crystal E. Schiller, J. M. Ncheka, Margaret P. Kasaro, Joan T. Price, Jeffrey S. A. Stringer, Elizabeth M. Stringer

    Introduction: Postpartum depression (PPD) is a prevalent and debilitating disease that may affect medication adherence and thus maternal health and vertical transmission among women with HIV. We assessed the feasibility of a trial of interpersonal psychotherapy (IPT) versus antidepressant medication (ADM) to treat PPD and/or anxiety among postpartum women with HIV in Lusaka, Zambia.Methods: Between 29 October 2019 and 8 September 2020, we pre‐screened women 6–8 weeks after delivery with the Edinburgh Postnatal Depression Scale (EPDS) and diagnosed PPD or anxiety with the Mini International Neuropsychiatric Interview. Consenting participants were randomized 1:1 to up to 11 sessions of IPT or daily self‐administered sertraline and followed for 24 weeks. We assessed EPDS score, Clinical Global Impression‐Severity of Illness (CGI‐S) and medication side effects at each visit and measured maternal HIV viral load at baseline and final study visit. Retention, visit adherence, change in EPDS, CGI‐S and log viral load were compared between groups with t‐tests and Wilcoxon signed rank tests; we report mean differences, relative risks and 95% confidence intervals. A participant satisfaction survey assessed trial acceptability.Results: 78/80 (98%) participants were retained at the final study visit. In the context of the COVID‐19 pandemic, visit adherence was greater among women allocated to ADM (9.9 visits, SD 2.2) versus IPT (8.9 visits, SD 2.4; p = 0.06). EPDS scores decreased from baseline to final visit overall, though mean change was greater in the IPT group (−13.8 points, SD 4.7) compared to the ADM group (−11.4 points, SD 5.5; p = 0.04). Both groups showed similar changes in mean log viral load from baseline to final study visit (mean difference −0.43, 95% CI −0.32, 1.18; p = 0.48). In the IPT group, viral load decreased significantly from baseline (0.9 log copies/ml, SD 1.7) to final visit (0.2 log copies/ml, SD 0.9; p = 0.01).Conclusions: This pilot study demonstrates that a trial of two forms of PPD treatment is feasible and acceptable among women with HIV in Zambia. IPT and ADM both improved measures of depression severity; however, a full‐scale trial is required to determine whether treatment of PPD and anxiety improves maternal–infant HIV outcomes.


  • Open Access

    Comparative effectiveness of in-person vs. remote delivery of the Common Elements Treatment Approach for addressing mental and behavioral health problems among adolescents and young adults in Zambia: protocol of a three-arm randomized controlled trial

    by Caleb J. Figge, Jeremy C. Kane, Stephanie Skavenski, Emily Haroz, Mwamba Mwenge, Saphira Mulemba, Luke R. Aldridge, Michael J. Vinikoor, Anjali Sharma, Sachi Inoue, et al.

    Background: In low- and middle-income countries (LMIC), there is a substantial gap in the treatment of mental and behavioral health problems, which is particularly detrimental to adolescents and young adults (AYA). The Common Elements Treatment Approach (CETA) is an evidence-based, flexible, transdiagnostic intervention delivered by lay counselors to address comorbid mental and behavioral health conditions, though its effectiveness has not yet been tested among AYA. This paper describes the protocol for a randomized controlled trial that will test the effectiveness of traditional in-person delivered CETA and a telehealth-adapted version of CETA (T-CETA) in reducing mental and behavioral health problems among AYA in Zambia. Non-inferiority of T-CETA will also be assessed. Methods: This study is a hybrid type 1 three-arm randomized trial to be conducted in Lusaka, Zambia. Following an apprenticeship model, experienced non-professional counselors in Zambia will be trained as CETA trainers using a remote, technology-delivered training method. The new CETA trainers will subsequently facilitate technology-delivered trainings for a new cohort of counselors recruited from community-based partner organizations throughout Lusaka. AYA with mental and behavioral health problems seeking services at these same organizations will then be identified and randomized to (1) in-person CETA delivery, (2) telehealth-delivered CETA (T-CETA), or (3) treatment as usual (TAU). In the superiority design, CETA and T-CETA will be compared to TAU, and using a non-inferiority design, T-CETA will be compared to CETA, which is already evidence-based in other populations. At baseline, post-treatment (approximately 3–4 months post-baseline), and 6 months post-treatment (approximately 9 months post-baseline), we will assess the primary outcomes such as client trauma symptoms, internalizing symptoms, and externalizing behaviors and secondary outcomes such as client substance use, aggression, violence, and health utility. CETA trainer and counselor competency and cost-effectiveness will also be measured as secondary outcomes. Mixed methods interviews will be conducted with trainers, counselors, and AYA participants to explore the feasibility, acceptability, and sustainability of technology-delivered training and T-CETA provision in the Zambian context. Discussion: Adolescents and young adults in LMIC are a priority population for the treatment of mental and behavioral health problems. Technology-delivered approaches to training and intervention delivery can expand the reach of evidence-based interventions. If found effective, CETA and T-CETA would help address a major barrier to the scale-up and sustainability of mental and behavioral treatments among AYA in LMIC. Trial registration: ClinicalTrials.gov NCT03458039. Prospectively registered on May 10, 2021


  • Efficacy of the Common Elements Treatment Approach (CETA) for Unhealthy Alcohol Use Among Adults with HIV in Zambia: Results from a Pilot Randomized Controlled Trial

    by Jeremy C. Kane, Anjali Sharma, Laura K. Murray, Geetanjali Chander, Tukiya Kanguya, Stephanie Skavenski, Chipo Chitambi, Molly E. Lasater, Ravi Paul, Karen Cropsey, et al.

    This randomized controlled trial tested the efficacy of a multi-session, evidence-based, lay counselor-delivered transdiagnostic therapy, the Common Elements Treatment Approach (CETA), in reducing unhealthy alcohol use and comorbidities among persons living with HIV (PLWH) in Zambia. Adult PLWH with (a) unhealthy alcohol use plus mental health or substance use comorbidities, or (b) severe unhealthy alcohol use were randomized to receive a single-session alcohol brief intervention (BI) alone or BI plus referral to CETA. Outcomes were measured at baseline and a 6-month follow-up and included Alcohol Use Disorders Identification Test (AUDIT) score (primary), depression and trauma symptoms, and other substance use (secondary). We enrolled 160 participants; 78 were randomized to BI alone and 82 to BI plus CETA. Due to COVID-19, the trial ended early before 36 participants completed. Statistically and clinically significant reductions in mean AUDIT score from baseline to 6-month follow-up were observed in both groups, however, participants assigned to BI plus CETA had significantly greater reductions compared to BI alone (− 3.2, 95% CI − 6.2 to − 0.1; Cohen’s d: 0.48). The CETA effect size for AUDIT score increased in line with increasing mental health/substance use comorbidity (0 comorbidities d = 0.25; 1–2 comorbidities d = 0.36; 3+ comorbidities d = 1.6). Significant CETA treatment effects were observed for depression, trauma, and several other substances. BI plus referral to CETA was feasible and superior to BI alone for unhealthy alcohol use among adults with HIV, particularly among those with comorbidities. Findings support future effectiveness testing of CETA for HIV outcomes among PLWH with unhealthy alcohol use. Clinical Trials Number: NCT03966885


  • Trends of Anticholinergics and Antipsychotics Prescribing at Chainama Hills College Hospital, Lusaka-Zambia

    by Francisca T Bwalya, James Mwanza, Paul Ravi

    Introduction:Antipsychotics are the main pharmacological treatment for psychosis. Anticholinergic drugs are sometimes prescribed with antipsychotics to treat or as prophylaxis for extrapyramidal side effects. Antipsychotic treatment guidelines recommend that anticholinergics should not be prescribed indiscriminately as prophylaxis for extrapyramidal side effects to patients using antipsychotic drugs, but only when there is high risk or evidence of extrapyramidal side effects, as they can cause significant central and peripheral side effects which have a potential to affect treatment outcomes. The objective of the study was to assess the trends in the prescribing of antipsychotics and anticholinergics.Methods:A cross sectional study was conducted at Chainama Hills College Hospital in Zambia. An open-ended questionnaire was administered to 26 prescribers and 311 files for patients were reviewed who had an antipsychotic or anticholinergic drug prescribed. The prescription pattern of patient files was compared with theNational Institute for Health and Care Excellenceguidelines as a gold standard.Results:The antipsychotic distribution showed that 76.1% were prescribed a typical antipsychotic, 18.1% an atypical antipsychotic and 5.8% were on both typical and atypical antipsychotic. 28.2% of the patients on antipsychotics were prescribed anticholinergics (Trihexyphenidyl). 46.2% of the prescribing clinicians stated that they prescribe anticholinergics when a patient develops extrapyramidal side effects rather than concurrently with antipsychotics or when a high dose of antipsychotics has been prescribed.Conclusion:The trend in antipsychotic and anticholinergic prescribing in Lusaka-Zambia were not consistent with recommended guidelines. Majority of patients are on typical antipsychotics rather than atypical antipsychotics. Most patients were administered above optimal dose of antipsychotics though polypharmacy was solemnly practiced. Recommend that further studies to explore factors contributing to this trend are conducted.

  • Open Access

    Effects of Supportive Group Therapy on Levels of Hopelessness in Patients with Cervical Cancer at Cancer Diseases Hospital in Lusaka, Zambia

    by Christine Mutelo, Paul Ravi, Joyce Ncheka

    Background: Hopelessness is a subjective appraisal of negative expectations about the occurrence of a highly valued outcome coupled with the sense that one lacks control over desired events in the future. Hopelessness is an early symptom of depression and is comorbid with cervical cancer. Supportive Group therapy offers an economical and time efficient solution. In Zambia and particularly at Cancer Disease Hospital such structured supportive group therapy is not being offered. This study aims to ascertain whether supportive group therapy can reduce levels of hopelessness in cervical cancer patients at Cancer disease hospital in Lusaka Zambia.Methodology: This was a double blinded Randomized Controlled Trial conducted at Cancer Disease Hospital in Lusaka Zambia. It wasconducted between March 2019 and September 2020. Patients with histologically confirmed diagnosis of cervical cancer were recruited. Sociodemographic characteristics and clinical presentations were elicited by detailed history taking and file review. All the participants completed PreHAI Questionnaire and their results were noted. They were then divided into a control and intervention group using computer generated numbers. The intervention group then attended one hour Supportive group therapy sessions weekly for four weeks. The control group continued to receive the usual support of their family members and Cancer disease hospital staff. Both groups were then administered the Post- HAI Questionnaire and their results were noted.Results: 49 patients were recruited. Patient retention was 92% (n= 45). Majority of the participants were of the age group 41-50 years i.e. control group (n =12) intervention group (n= 7). Majority were; married control (n= 11) intervention (n= 12), unemployed control (n=14) intervention (n= 18), had social support control (n=14) intervention (n= 18). Only social support correlated with lower HAI scores (p= 0.047). There was no correlation between therapy and post HAI scores as both p- values i.e. control (p= 0.683) intervention (p= 0.368) were greater than confidence interval 0.05. The intervention group had a greater reduction in HAI scores from (p= 0.621 to p= 0.368) in comparison to the control group (p= 0.707 to p= 0.683).Conclusion: There was a difference (yet statistically insignificant) in treatment outcomes of cervical cancer patients receiving supportive group therapy to those not receiving supportive group therapy. That is to say that the intervention group showed a greater reduction in HAI scores in comparison to the control group. Social support is the only significant factor associated with lower levels of hopelessness.